Thumbnail Image
Item

First-line therapy (1L) of cisplatin/gemcitabine (CisGem) with pembrolizumab (pembro) in patients with advanced biliary tract cancer (aBTC): open-label, single-arm phase II EORTC-1607-GITCG/ABC-09 intergroup study with translational research (TR)

Moehler, M.
; 
Maderer, A.
; 
Wagner, D. C.
; 
McNamara, M. G.
; 
Bridgewater, A.
; 
Arora, A.
; 
Mercade, T. M.
; 
Adeva, J. A.
; 
Hubner, R.
; 
Lordick, F.
... show 8 more
Citations
Google Scholar:
Lookup
Altmetric:
Abstract
Authors
Moehler, M.
Maderer, A.
Wagner, D. C.
McNamara, M. G.
Bridgewater, A.
Arora, A.
Mercade, T. M.
Adeva, J. A.
Hubner, R.
Lordick, F.
Foerster, F.
Weinmann, A.
Galle, P. R.
Leurquin, B.
Marreaud, S. I.
Mauer, M. E.
Valle, J. W.
Lamarca, A.
Affiliation
Johannes Gutenberg Univ Mainz, Univ Med, Dept Med, Mainz, Germany Univ Clin Mainz, Dept Internal Med I, Mainz, Germany Johannes Gutenberg Univ Mainz, Univ Med, Inst Pathol, Mainz, Germany Christie NHS Fdn Trust, Med Oncol Dept, Manchester, England UCL Canc Inst, Med Oncol Dept, Paul OGorman Bldg, London, England Nottingham City Hosp, Oncol Dept, Nottingham, England VHIO Vall dHebron Inst Oncol, Med Oncol Dept, Barcelona, Spain Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain Christie NHS Fdn Trust, Upper GI, Manchester, England Univ Klinikum Leipzig, Univ Krebszentrum Leipzig, Dept Med, Leipzig, Germany Univ Med Ctr Mainz, Dept Med 1, Mainz, Germany Johannes Gutenberg Univ Mainz, Univ Med Ctr, Med Dept 1, Mainz, Germany Johannes Gutenberg Univ Mainz, Univ Med, Dept Internal Med 1, Mainz, Germany EORTC AISBL IVZW European Org Res & Treatment Canc, Stat, Brussels, Belgium EORTC AISBL IVZW European Org Res & Treatment Canc, Med Dept, Brussels, Belgium Cholangiocarcinoma Fdn, Res, Herriman, UT USA Hosp Univ Fdn Jimenez Diaz, Med Oncol Dept, Madrid, Spain
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
Found from Unpaywall
Adobe PDF, 132.47 KB
Keywords
Type
Article
Citation
Moehler M, Maderer A, Wagner DC, McNamara MG, Bridgewater A, Arora A, et al. First-line therapy (1L) of cisplatin/gemcitabine (CisGem) with pembrolizumab (pembro) in patients with advanced biliary tract cancer (aBTC): Open-label, single-arm phase II EORTC-1607-GITCG/ABC-09 intergroup study with translational research (TR). ANNALS OF ONCOLOGY. 2025 JUL;36:S125-S. PubMed PMID: WOS:001545624000001. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627753
Embedded videos